Payment overview · 2025
General Payments
$328.51
5 reported records · 4 companies
Healthcare provider profile · identity verified
Roger A. Smith, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · WISNER, LA · NPI 1023045671
Verified facts
What the public records show
CMS Open Payments records show Roger A. Smith, M.D. received $328.51 in general payments during 2025 across 5 reported records.
INTUITIVE SURGICAL, INC. accounted for 81.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 114 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $268.00 | 81.6% | 2 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $21.27 | 6.5% | 1 | 2025 |
| Neurelis, Inc. |
Neurelis, Inc. exact · evidence 2025-02-20 |
$20.93 | 6.4% | 1 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $18.31 | 5.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Travel and Lodging | $268.00 | 2 |
| Food and Beverage | $60.51 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $268.00 | 2 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Lilly USA, LLC | $21.27 | 1 | 2025 |
Source payment records
|
|||||
| VALTOCO Normalized: valtoco |
Drug | Neurelis, Inc. | $20.93 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $18.31 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 114 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
114 | 20 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
51 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 931 | 130 |
| Gabapentin | Gabapentin | 879 | 130 |
| Pantoprazole Sodium | Pantoprazole Sodium | 852 | 119 |
| Furosemide | Furosemide | 842 | 108 |
| Amlodipine Besylate | Amlodipine Besylate | 827 | 158 |
| Levothyroxine Sodium | Levothyroxine Sodium | 814 | 105 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 700 | 96 |
| Clopidogrel | Clopidogrel Bisulfate | 636 | 81 |
| Potassium Chloride | Potassium Chloride | 525 | 87 |
| Lisinopril | Lisinopril | 502 | 92 |
| Eliquis | Apixaban | 490 | 53 |
| Alprazolam | Alprazolam | 484 | 66 |
| Metoprolol Tartrate | Metoprolol Tartrate | 413 | 65 |
| Tamsulosin Hcl | Tamsulosin Hcl | 413 | 69 |
| Metoprolol Succinate | Metoprolol Succinate | 403 | 53 |
| Losartan Potassium | Losartan Potassium | 399 | 76 |
| Omeprazole | Omeprazole | 389 | 73 |
| Metformin Hcl | Metformin Hcl | 386 | 84 |
| Tramadol Hcl | Tramadol Hcl | 365 | 73 |
| Hydrochlorothiazide | Hydrochlorothiazide | 324 | 63 |
| Memantine Hcl | Memantine Hcl | 321 | 33 |
| Carvedilol | Carvedilol | 298 | 47 |
| Simvastatin | Simvastatin | 295 | 53 |
| Meloxicam | Meloxicam | 290 | 47 |
| Sertraline Hcl | Sertraline Hcl | 274 | 47 |
| Donepezil Hcl | Donepezil Hcl | 270 | 41 |
| Montelukast Sodium | Montelukast Sodium | 240 | 35 |
| Pravastatin Sodium | Pravastatin Sodium | 225 | 42 |
| Naproxen | Naproxen | 220 | 54 |
| Trazodone Hcl | Trazodone Hcl | 220 | 40 |
| Nifedipine Er | Nifedipine | 210 | 29 |
| Quetiapine Fumarate | Quetiapine Fumarate | 194 | 21 |
| Clonazepam | Clonazepam | 191 | 23 |
| Escitalopram Oxalate | Escitalopram Oxalate | 185 | 32 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 181 | 34 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 177 | 26 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 176 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 173 | 41 |
| Allopurinol | Allopurinol | 173 | 30 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 172 | 29 |
| Levetiracetam | Levetiracetam | 168 | 19 |
| Entresto | Sacubitril/Valsartan | 166 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 162 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 159 | 30 |
| Fluoxetine Hcl | Fluoxetine Hcl | 156 | 23 |
| Rivastigmine | Rivastigmine Tartrate | 152 | 15 |
| Januvia | Sitagliptin Phosphate | 146 | suppressed |
| Temazepam | Temazepam | 125 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 125 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 120 | 28 |
| Lorazepam | Lorazepam | 118 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 115 | 41 |
| Amiodarone Hcl | Amiodarone Hcl | 114 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 114 | 30 |
| Jardiance | Empagliflozin | 114 | 20 |
| Sucralfate | Sucralfate | 113 | 14 |
| Famotidine | Famotidine | 108 | 19 |
| Amitriptyline Hcl | Amitriptyline Hcl | 105 | 21 |
| Ibuprofen | Ibuprofen | 100 | 25 |
| Buspirone Hcl | Buspirone Hcl | 98 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 96 | 15 |
| Glimepiride | Glimepiride | 95 | 20 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 95 | 19 |
| Mirtazapine | Mirtazapine | 95 | 14 |
| Prednisone | Prednisone | 93 | 28 |
| Risperidone | Risperidone | 93 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 92 | 22 |
| Glipizide | Glipizide | 92 | 15 |
| Celecoxib | Celecoxib | 91 | 19 |
| Paroxetine Hcl | Paroxetine Hcl | 91 | 17 |
| Rexulti | Brexpiprazole | 89 | suppressed |
| Xarelto | Rivaroxaban | 88 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 87 | 34 |
| Meclizine Hcl | Meclizine Hcl | 86 | 20 |
| Spironolactone | Spironolactone | 86 | 16 |
| Atenolol | Atenolol | 85 | 17 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 84 | suppressed |
| Olanzapine | Olanzapine | 84 | 11 |
| Divalproex Sodium | Divalproex Sodium | 82 | suppressed |
| Linzess | Linaclotide | 82 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 81 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 76 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 76 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 74 | 17 |
| Alendronate Sodium | Alendronate Sodium | 72 | 15 |
| Finasteride | Finasteride | 69 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 69 | suppressed |
| Pregabalin | Pregabalin | 68 | 14 |
| Bumetanide | Bumetanide | 67 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 66 | 23 |
| Ezetimibe | Ezetimibe | 65 | 15 |
| Fenofibrate | Fenofibrate Nanocrystallized | 61 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 61 | 16 |
| Clonidine Hcl | Clonidine Hcl | 60 | 14 |
| Divalproex Sodium Er | Divalproex Sodium | 60 | suppressed |
| Aripiprazole | Aripiprazole | 59 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 58 | 11 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 56 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 56 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 53 | 17 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 53 | 13 |
| Metolazone | Metolazone | 53 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 53 | 13 |
| Farxiga | Dapagliflozin Propanediol | 52 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 51 | 11 |
| Trulicity | Dulaglutide | 51 | suppressed |
| Rivastigmine | Rivastigmine | 49 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 49 | 13 |
| Methocarbamol | Methocarbamol | 48 | 15 |
| Lactulose | Lactulose | 47 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 47 | suppressed |
| Novolog Flexpen | Insulin Aspart | 47 | suppressed |
| Estradiol | Estradiol | 46 | suppressed |
| Amantadine | Amantadine Hcl | 45 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 45 | suppressed |
| Digoxin | Digoxin | 44 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 44 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 44 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 42 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 42 | suppressed |
| Tradjenta | Linagliptin | 42 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 41 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 40 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 40 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 40 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 40 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 39 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 39 | 37 |
| Torsemide | Torsemide | 39 | 13 |
| Valsartan | Valsartan | 39 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 38 | suppressed |
| Acetazolamide | Acetazolamide | 37 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 37 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 37 | suppressed |
| Carbamazepine | Carbamazepine | 36 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 36 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 36 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 36 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 36 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 36 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 36 | suppressed |
| Lacosamide | Lacosamide | 35 | suppressed |
| Ozempic | Semaglutide | 35 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 35 | suppressed |
| Diazepam | Diazepam | 34 | suppressed |
| Latanoprost | Latanoprost | 34 | suppressed |
| Ondansetron Odt | Ondansetron | 34 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 34 | suppressed |
| Gemtesa | Vibegron | 32 | suppressed |
| Lamotrigine | Lamotrigine | 32 | suppressed |
| Primidone | Primidone | 32 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 32 | suppressed |
| Nystatin | Nystatin | 31 | 13 |
| Fentanyl | Fentanyl | 30 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 30 | 30 |
| Mitigare | Colchicine | 29 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 29 | suppressed |
| Amoxicillin | Amoxicillin | 28 | 22 |
| Benztropine Mesylate | Benztropine Mesylate | 28 | suppressed |
| Colchicine | Colchicine | 28 | 11 |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 28 | suppressed |
| Mounjaro | Tirzepatide | 28 | suppressed |
| Baclofen | Baclofen | 27 | suppressed |
| Cilostazol | Cilostazol | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 13 |
| Entacapone | Entacapone | 27 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 27 | suppressed |
| Topiramate | Topiramate | 27 | suppressed |
| Mupirocin | Mupirocin | 26 | 18 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 26 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 26 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 26 | suppressed |
| Verapamil Er | Verapamil Hcl | 26 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 23 | suppressed |
| Sotalol | Sotalol Hcl | 23 | suppressed |
| Clobazam | Clobazam | 22 | suppressed |
| Fluconazole | Fluconazole | 22 | 15 |
| Lubiprostone | Lubiprostone | 22 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 22 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 21 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 21 | suppressed |
| Timolol Maleate | Timolol Maleate | 21 | suppressed |
| Azithromycin | Azithromycin | 20 | 19 |
| Brimonidine Tartrate | Brimonidine Tartrate | 20 | suppressed |
| Bupropion Xl | Bupropion Hcl | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 19 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 19 | suppressed |
| Pentoxifylline | Pentoxifylline | 19 | suppressed |
| Ramipril | Ramipril | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Cephalexin | Cephalexin | 18 | 15 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Carbidopa-Levodopa-Entacapone | Carbidopa/Levodopa/Entacapone | 17 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 17 | 16 |
| Clonidine | Clonidine | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 17 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Glyburide | Glyburide | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 16 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 15 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 15 | 12 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Motegrity | Prucalopride Succinate | 15 | suppressed |
| Phenytoin | Phenytoin | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 15 | suppressed |
| Scopolamine | Scopolamine | 15 | suppressed |
| Trimethoprim | Trimethoprim | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Indomethacin | Indomethacin | 14 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 14 | suppressed |
| Ssd | Silver Sulfadiazine | 14 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 13 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 13 | 12 |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Armour Thyroid | Thyroid,pork | 12 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Invokana | Canagliflozin | 12 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Nateglinide | Nateglinide | 12 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Odefsey | Emtricitab/Rilpiviri/Tenof Ala | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Thioridazine Hcl | Thioridazine Hcl | 12 | suppressed |
| Tivicay | Dolutegravir Sodium | 12 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Fluocinonide | Fluocinonide | 11 | suppressed |
| Fluticasone-Salmeterol Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 11 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 11 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 11 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 11 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 11 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $328.51 · 5 records | INTUITIVE SURGICAL, INC. | Auvelity, Da Vinci Surgical System, JARDIANCE, VALTOCO | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error